Related Experiment Video

Updated: Jun 11, 2025

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
08:36

Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3

Published on: April 7, 2023

1.0K

Recalcitrant cutaneous sarcoidosis treated with upadacitinib: Case report

Mohannad Safadi1, Kathleen Whittington2, Scott Zahner3

  • 1Internal Medicine Department, University of Illinois College of Medicine, Chicago, Illinois.

JAAD Case Reports
|September 30, 2024
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Janus kinasecutaneous sarcoidosisgeneral dermatologygranulomatous inflammationlupus perniomedical dermatologysarcoidosisupadacitinib

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

393
Anterior Capsular Reconstruction with Human Dermal Allograft for Irreparable Subscapularis Tears04:27

Anterior Capsular Reconstruction with Human Dermal Allograft for Irreparable Subscapularis Tears

Published on: May 9, 2025

32

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.7K